2022
DOI: 10.1101/2022.06.04.22275989
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study

Abstract: Aims and objectives: To assess the levels of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses and explore the potential predictors of vaccine hesitancy. Background: COVID-19 full vaccination seems to be highly effective against highly contagious variants of SARS-CoV-2. Healthcare workers are a high-risk group since they have experienced high levels of COVID-19-associated morbidity and mortality. Methods: An on-line cross-sectional study was carried out in Greece in May 2022, using a … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…As in other studies, the most common concerns among hesitant individuals involved safety (n = 45; 18.4%), side-effects (delineated between short- (n = 55; 22.4%) and long- (n = 115; 46.9%) term effects), and efficacy (n = 90; 36.7%) were the most common, which is intriguing given this group had already received COVID-19 immunization. This study also notes a unique reason for hesitancy: being fatigued with the “vaccination process” (n = 60; 24.5%) [ 25 ]. Similarly, this study observed a relatively low rate of booster vaccination (50% of vaccinated respondents) despite a much higher rate of overall vaccination, an observation that may warrant future studies.…”
Section: Discussionmentioning
confidence: 99%
“…As in other studies, the most common concerns among hesitant individuals involved safety (n = 45; 18.4%), side-effects (delineated between short- (n = 55; 22.4%) and long- (n = 115; 46.9%) term effects), and efficacy (n = 90; 36.7%) were the most common, which is intriguing given this group had already received COVID-19 immunization. This study also notes a unique reason for hesitancy: being fatigued with the “vaccination process” (n = 60; 24.5%) [ 25 ]. Similarly, this study observed a relatively low rate of booster vaccination (50% of vaccinated respondents) despite a much higher rate of overall vaccination, an observation that may warrant future studies.…”
Section: Discussionmentioning
confidence: 99%